PureTech Health plc

OTC: PTCHF · Healthcare · Biotechnology

PublicHQ Boston, MA · SuffolkCIK 0001782999Reports USD

#1 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 61

v0.1 · 5/100 weight · pillars only

↑ return on assets, return on equity · ↓ filing timeliness, Piotroski F

Methodology →

Revenue TTM

$9.0M

Rev growth YoY (TTM)

-52.4%

Net income (FY)

$27.8M

Employees

as of 2026-08-12

Market cap

$380.9M

as of 2026-08-12

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income$27.8M$27.8M2024

Total assets$602.6M$602.6M2024

Liabilities$194.7M$194.7M2024

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is PureTech Health plc’s financial profile?

PureTech Health plc earned $27.8M in FY2024 net income.

Peers · Healthcare

Kyverna Therapeutics, Inc.——Cabaletta Bio, Inc.——Rezolute, Inc.——Mobia Medical, Inc. Common Stock——Scribe Therapeutics Inc.——Neumora Therapeutics, Inc. Common Stock——

Neighbors

Suffolk →

Vertex Pharmaceuticals Incorporated$12.0B88A American Tower Corporation$935.9M76B+State Street Corporation$13.9B67B NSTAR Electric Company——Toast, Inc.$6.2B67B PTC Inc.$2.7B83B+

Key facts

CEORobert Lyne

SectorHealthcare

IndustryBiotechnology

HeadquartersBoston, MA

ExchangeOTC: PTCHF

Employees80

IPO date2015-07-29

Latest filings

6-K2026-05-01 6-K2026-04-29 20-F2026-04-29 6-K2026-04-29 6-K2025-12-18 6-K2025-12-10 6-K2025-08-28 6-K2025-07-16

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.